Follow
Michael Rafii
Michael Rafii
USC ATRI
Verified email at usc.edu
Title
Cited by
Cited by
Year
Down syndrome
SE Antonarakis, BG Skotko, MS Rafii, A Strydom, SE Pape, DW Bianchi, ...
Nature Reviews Disease Primers 6 (1), 9, 2020
5772020
Recent developments in Alzheimer's disease therapeutics
MS Rafii, PS Aisen
BMC medicine 7, 1-4, 2009
2752009
Safety, efficacy, and feasibility of intranasal insulin for the treatment of mild cognitive impairment and Alzheimer disease dementia: a randomized clinical trial
S Craft, R Raman, TW Chow, MS Rafii, CK Sun, RA Rissman, ...
JAMA neurology 77 (9), 1099-1109, 2020
2422020
A phase II trial of huperzine A in mild to moderate Alzheimer disease
MS Rafii, S Walsh, JT Little, K Behan, B Reynolds, C Ward, S Jin, ...
Neurology 76 (16), 1389-1394, 2011
2412011
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease
MS Rafii, TL Baumann, RAE Bakay, JM Ostrove, J Siffert, AS Fleisher, ...
Alzheimer's & Dementia 10 (5), 571-581, 2014
2172014
Agrin and microvascular damage in Alzheimer’s disease
TM Berzin, BD Zipser, MS Rafii, V Kuo—Leblanc, GD Yancopouloš, ...
Neurobiology of aging 21 (2), 349-355, 2000
2122000
Adeno-associated viral vector (serotype 2)–nerve growth factor for patients with alzheimer disease: a randomized clinical trial
MS Rafii, MH Tuszynski, RG Thomas, D Barba, JB Brewer, RA Rissman, ...
JAMA neurology 75 (7), 834-841, 2018
1622018
A phase 3 trial of IV immunoglobulin for Alzheimer disease
NR Relkin, RG Thomas, RA Rissman, JB Brewer, MS Rafii, CH Van Dyck, ...
Neurology 88 (18), 1768-1775, 2017
1612017
High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment
S Kovacevic, MS Rafii, JB Brewer, ...
Alzheimer Disease & Associated Disorders 23 (2), 139-145, 2009
1412009
Outcome measures for clinical trials in Down syndrome
AJ Esbensen, SR Hooper, D Fidler, SL Hartley, J Edgin, XL d'Ardhuy, ...
American journal on intellectual and developmental disabilities 122 (3), 247-281, 2017
1322017
Agrin in Alzheimer’s disease: altered solubility and abnormal distribution within microvasculature and brain parenchyma
JE Donahue, TM Berzin, MS Rafii, DJ Glass, GD Yancopoulos, JR Fallon, ...
Proceedings of the National Academy of Sciences 96 (11), 6468-6472, 1999
1271999
Advances in Alzheimer’s disease drug development
MS Rafii, PS Aisen
BMC medicine 13 (1), 62, 2015
1252015
Alzheimer's disease associated with Down syndrome: a genetic form of dementia
J Fortea, SH Zaman, S Hartley, MS Rafii, E Head, M Carmona-Iragui
The Lancet Neurology 20 (11), 930-942, 2021
1142021
Effect of AZD0530 on cerebral metabolic decline in Alzheimer disease: a randomized clinical trial
CH Van Dyck, HB Nygaard, K Chen, MC Donohue, R Raman, ...
JAMA neurology 76 (10), 1219-1229, 2019
1142019
The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the evaluation and management of dementia in adults with intellectual …
JA Moran, MS Rafii, SM Keller, BK Singh, MP Janicki
Mayo Clinic Proceedings 88 (8), 831-840, 2013
1022013
Evidence for a postnatal doubling of neuron number in the developing human cerebral cortex between 15 months and 6 years
WR Shankle, BH Landing, MS Rafii, A Schiano, JM Chen, J Hara
Journal of Theoretical Biology 191 (2), 115-140, 1998
881998
PET imaging of tau pathology and relationship to amyloid, longitudinal MRI, and cognitive change in Down syndrome: results from the Down Syndrome Biomarker Initiative (DSBI)
MS Rafii, AS Lukic, RD Andrews, J Brewer, RA Rissman, SC Strother, ...
Journal of Alzheimer's Disease 60 (2), 439-450, 2017
862017
The down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer’s disease biomarkers in down syndrome
MS Rafii, H Wishnek, JB Brewer, MC Donohue, S Ness, WC Mobley, ...
Frontiers in behavioral neuroscience 9, 239, 2015
832015
Biglycan binds to α‐and γ‐sarcoglycan and regulates their expression during development
MS Rafii, H Hagiwara, ML Mercado, NS Seo, T Xu, T Dugan, RT Owens, ...
Journal of cellular physiology 209 (2), 439-447, 2006
812006
Approximate doubling of numbers of neurons in postnatal human cerebral cortex and in 35 specific cytoarchitectural areas from birth to 72 months
WR Shankle, MS Rafii, BH Landing, JH Fallon
Pediatric and developmental pathology 2 (3), 244-259, 1999
781999
The system can't perform the operation now. Try again later.
Articles 1–20